Foghorn Therapeutics
FHTX
#9648
Rank
A$0.15 B
Marketcap
A$2.60
Share price
-3.37%
Change (1 day)
-63.67%
Change (1 year)

Earnings for Foghorn Therapeutics (FHTX)

Earnings in 2026 (TTM): -A$0.11 Billion

According to Foghorn Therapeutics's latest financial reports the company's current earnings are A$36.73 Million. In 2025 the company made an earning of -A$0.13 Billion, an increase over its 2024 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Foghorn Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.11 Billion-18.46%
2025 -A$0.13 Billion-18.13%
2024 -A$0.16 Billion-7.06%
2023 -A$0.17 Billion-5.46%
2022 -A$0.18 Billion14.81%
2021 -A$0.16 Billion46.58%
2020 -A$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 128.02%๐Ÿ‡บ๐Ÿ‡ธ USA